ACTRN12613000831785已完成1 期
A Phase I, Proof of Concept, Open Label, Escalating Dose Study to Assess the Safety, Tolerability and Immunogenicity of a Herpes Simplex Virus (HSV) Deoxyribonucleic Acid (DNA) Vaccine in Healthy Volunteers
Coridon Pty Ltd0 个研究点目标入组 20 人开始时间: 2013年7月29日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Prevention
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 45 Years（—）
- 性别
- All
入选标准
- •HSV-1 and 2 seronegative
- •Generally healthy
- •No birthmarks, tattoos, wounds or skin conditions on either forearm
排除标准
- •Suffering acute or chronic disease
- •Pregant or nursing females
- •HSV, Hepatitis B or C, or HIV seropositive
研究者
相似试验
招募中
1 期
A Study of AG-946 in Participants With Anaemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS).CTIS2022-500609-42-00Agios Pharmaceuticals Inc.117
尚未招募
1 期
A Phase 1b Open-Label, Proof of Concept Study to Evaluate the Safety and Efficacy of Novel Hepatitis B Virus (HBV) Combination Therapies in Chronic Hepatitis B (CHB) SubjectsHepatitis BACTRN12618001843246Gilead Sciences, Inc36
进行中（未招募）
1 期
A study to investigate the tolerance and safety of treatment in patients with preeclampsiaPreeclampsiaEUCTR2018-002904-14-NLPharming Technologies B.V.30
已完成
2 期
A Phase I/II, Open Label, Proof of Concept Study to investigate Tolerability and Safety of Treatment with Recombinant Human C1 Inhibitor (conestat alfa) in Patients with Preeclampsia.NL-OMON48732Pharming Technologies B.V.15
进行中（未招募）
1 期
Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients withXeroderma Pigmentosum (XP)EUCTR2019-000597-34-DECLINUVEL EUROPE LIMITED6